Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials

Authors: Bhatt, Ankeet S | Journal Of The American Heart Association | March 5, 2024 | PubMed abstract

Explore all publications

Back To Top